vs
Side-by-side financial comparison of Natera, Inc. (NTRA) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.
Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $334.0M, roughly 2.0× WYNDHAM HOTELS & RESORTS, INC.). Natera, Inc. runs the higher net margin — 7.1% vs -18.0%, a 25.1% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -76.3%). WYNDHAM HOTELS & RESORTS, INC. produced more free cash flow last quarter ($168.0M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -4.6%).
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.
NTRA vs WH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $665.5M | $334.0M |
| Net Profit | $47.3M | $-60.0M |
| Gross Margin | — | — |
| Operating Margin | -3.4% | — |
| Net Margin | 7.1% | -18.0% |
| Revenue YoY | 39.8% | -76.3% |
| Net Profit YoY | 187.9% | -170.6% |
| EPS (diluted) | $0.36 | $-0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $334.0M | ||
| Q4 25 | $665.5M | $334.0M | ||
| Q3 25 | $592.2M | $382.0M | ||
| Q2 25 | $546.6M | $397.0M | ||
| Q1 25 | $501.8M | $316.0M | ||
| Q4 24 | $476.1M | $336.0M | ||
| Q3 24 | $439.8M | $396.0M | ||
| Q2 24 | $413.4M | $367.0M |
| Q1 26 | — | $-60.0M | ||
| Q4 25 | $47.3M | $-60.0M | ||
| Q3 25 | $-87.5M | $105.0M | ||
| Q2 25 | $-100.9M | $87.0M | ||
| Q1 25 | $-66.9M | $61.0M | ||
| Q4 24 | $-53.8M | $85.0M | ||
| Q3 24 | $-31.6M | $102.0M | ||
| Q2 24 | $-37.5M | $86.0M |
| Q1 26 | — | — | ||
| Q4 25 | -3.4% | -11.4% | ||
| Q3 25 | -16.5% | 46.6% | ||
| Q2 25 | -20.2% | 37.8% | ||
| Q1 25 | -15.8% | 35.4% | ||
| Q4 24 | -13.6% | 38.4% | ||
| Q3 24 | -8.9% | 43.2% | ||
| Q2 24 | -10.6% | 39.5% |
| Q1 26 | — | -18.0% | ||
| Q4 25 | 7.1% | -18.0% | ||
| Q3 25 | -14.8% | 27.5% | ||
| Q2 25 | -18.5% | 21.9% | ||
| Q1 25 | -13.3% | 19.3% | ||
| Q4 24 | -11.3% | 25.3% | ||
| Q3 24 | -7.2% | 25.8% | ||
| Q2 24 | -9.1% | 23.4% |
| Q1 26 | — | $-0.80 | ||
| Q4 25 | $0.36 | $-0.77 | ||
| Q3 25 | $-0.64 | $1.36 | ||
| Q2 25 | $-0.74 | $1.13 | ||
| Q1 25 | $-0.50 | $0.78 | ||
| Q4 24 | $-0.41 | $1.06 | ||
| Q3 24 | $-0.26 | $1.29 | ||
| Q2 24 | $-0.30 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $64.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $468.0M |
| Total Assets | $2.4B | $4.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.0M | ||
| Q4 25 | — | $64.0M | ||
| Q3 25 | $1.0M | $70.0M | ||
| Q2 25 | $16.0M | $50.0M | ||
| Q1 25 | $17.8M | $48.0M | ||
| Q4 24 | $22.7M | $103.0M | ||
| Q3 24 | $29.5M | $72.0M | ||
| Q2 24 | $90.3M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $468.0M | ||
| Q4 25 | $1.7B | $468.0M | ||
| Q3 25 | $1.3B | $583.0M | ||
| Q2 25 | $1.2B | $570.0M | ||
| Q1 25 | $1.2B | $579.0M | ||
| Q4 24 | $1.2B | $650.0M | ||
| Q3 24 | $878.5M | $583.0M | ||
| Q2 24 | $836.5M | $623.0M |
| Q1 26 | — | $4.2B | ||
| Q4 25 | $2.4B | $4.2B | ||
| Q3 25 | $1.8B | $4.3B | ||
| Q2 25 | $1.8B | $4.3B | ||
| Q1 25 | $1.7B | $4.2B | ||
| Q4 24 | $1.7B | $4.2B | ||
| Q3 24 | $1.6B | $4.2B | ||
| Q2 24 | $1.5B | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.37× | ||
| Q3 25 | — | 4.43× | ||
| Q2 25 | — | 4.44× | ||
| Q1 25 | — | 4.29× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | — | 4.19× | ||
| Q2 24 | — | 3.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.9M | $367.0M |
| Free Cash FlowOCF − Capex | $37.8M | $168.0M |
| FCF MarginFCF / Revenue | 5.7% | 50.3% |
| Capex IntensityCapex / Revenue | 5.4% | — |
| Cash ConversionOCF / Net Profit | 1.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | $109.1M | $437.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $367.0M | ||
| Q4 25 | $73.9M | $152.0M | ||
| Q3 25 | $59.4M | $86.0M | ||
| Q2 25 | $37.6M | $70.0M | ||
| Q1 25 | $44.5M | $59.0M | ||
| Q4 24 | $52.9M | $134.0M | ||
| Q3 24 | $51.8M | $79.0M | ||
| Q2 24 | $4.0M | $1.0M |
| Q1 26 | — | $168.0M | ||
| Q4 25 | $37.8M | $136.0M | ||
| Q3 25 | $37.0M | $75.0M | ||
| Q2 25 | $11.7M | $58.0M | ||
| Q1 25 | $22.6M | $52.0M | ||
| Q4 24 | $34.8M | $109.0M | ||
| Q3 24 | $35.5M | $71.0M | ||
| Q2 24 | $-7.7M | $-6.0M |
| Q1 26 | — | 50.3% | ||
| Q4 25 | 5.7% | 40.7% | ||
| Q3 25 | 6.2% | 19.6% | ||
| Q2 25 | 2.1% | 14.6% | ||
| Q1 25 | 4.5% | 16.5% | ||
| Q4 24 | 7.3% | 32.4% | ||
| Q3 24 | 8.1% | 17.9% | ||
| Q2 24 | -1.9% | -1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | 4.8% | ||
| Q3 25 | 3.8% | 2.9% | ||
| Q2 25 | 4.7% | 3.0% | ||
| Q1 25 | 4.3% | 2.2% | ||
| Q4 24 | 3.8% | 7.4% | ||
| Q3 24 | 3.7% | 2.0% | ||
| Q2 24 | 2.8% | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.56× | — | ||
| Q3 25 | — | 0.82× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 0.97× | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTRA
Segment breakdown not available.
WH
| Fee-related and other revenues | $334.0M | 100% |
| Management and other fees | $2.0M | 1% |
